104 related articles for article (PubMed ID: 7201814)
1. [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].
Gikalov I; Kaufmann R; Schuster O
Arzneimittelforschung; 1982; 32(4):423-6. PubMed ID: 7201814
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
3. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)].
Faust-Tinnefeldt G; Gilfrich HJ
Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114
[TBL] [Abstract][Full Text] [Related]
4. [On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography (author's transl)].
Geissler HE; Mutschler E; Faust-Tinnefeldt G
Arzneimittelforschung; 1977; 27(9):1713-5. PubMed ID: 579143
[TBL] [Abstract][Full Text] [Related]
5. [Determination of azapropazone and 8-hydroxyazapropazone in urine by direct quantitative thin-layer chromatography (author's transl)].
Geissler HE; Faust-Tinnefeldt G; Mutschler E
Arzneimittelforschung; 1978; 28(8):1430-1. PubMed ID: 582413
[TBL] [Abstract][Full Text] [Related]
6. The determination of azapropazone and its 6-hydroxy metabolite in plasma and urine by HPLC.
Kline BJ; Wood JH; Beightol LA
Arzneimittelforschung; 1983; 33(4):504-6. PubMed ID: 6683526
[TBL] [Abstract][Full Text] [Related]
7. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of azapropazone in the elderly.
Ritch AE; Perera WN; Jones CJ
Br J Clin Pharmacol; 1982 Jul; 14(1):116-9. PubMed ID: 7104163
[TBL] [Abstract][Full Text] [Related]
11. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
[TBL] [Abstract][Full Text] [Related]
13. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
14. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
15. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
[TBL] [Abstract][Full Text] [Related]
16. Distribution of azapropazone and its principal 8-hydroxy-metabolite in plasma, urine and gastrointestinal mucosa determined by HPLC.
Rainsford KD
J Pharm Pharmacol; 1985 May; 37(5):341-5. PubMed ID: 2862244
[TBL] [Abstract][Full Text] [Related]
17. Concentration of azapropazone in synovial tissues and fluid.
Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of bromfenac in healthy subjects after single oral administration of three different doses.
Högger P; Rohdewald P
Arzneimittelforschung; 1993 Oct; 43(10):1114-8. PubMed ID: 8267679
[TBL] [Abstract][Full Text] [Related]
19. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics.
Hao X; Cheng G; Sun J; Zou M; Yu J; Zhang S; Cui F
J Pharm Biomed Anal; 2005 Jun; 38(2):360-3. PubMed ID: 15925232
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
